[Skip to Navigation]
Editor's Correspondence
November 13, 2006

Clopidogrel in Patients With Acute Coronary Syndromes: Learning From Clinical Practice—Reply

Arch Intern Med. 2006;166(20):2293. doi:10.1001/archinte.166.20.2293

In reply

We appreciate the interest and the comments by Ziegelstein regarding our article.1 Ziegelstein pointed out that the lack of long-term clopidogrel use among patients with NSTE ACS may be related to the fact that the guideline recommendation regarding use of clopidogrel after discharge is currently based on the results of only 1 clinical trial, the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial.2 Moreover, Ziegelstein found the results of the CURE trial itself not convincing, because the benefit of clopidogrel was partially counterbalanced by an increased bleeding risk.

Add or change institution